As of December 13, 2023, our company name has changed from E.P.Medical Inc. to Epsilon Medical Inc. We appreciate your…

MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P.…

We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and…

We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…